[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"delivery-complication\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:delivery-complication":45},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,6,0,[8,86,117,147,174,211],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":4,"studyType":24,"phases":25,"briefSummary":27,"conditions":28,"keywords":46,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":85},"100569405","advanced-wireless-sensors-for-neonatal-care-in-the-delivery-room-100569405",false,"NCT06693817","Advanced Wireless Sensors for Neonatal Care in the Delivery Room","Advanced Wireless Sensors for Neonatal Care in the Delivery Room: the AWARD Prospective Multicenter International Study","AWARD","Inclusion criteria:\n\n1. Newborns ≥35 weeks (gestational age)\n2. Newborns determined to be clinically stable at delivery\n3. Newborns with no skin abnormalities\n\nExclusion criteria:\n\n1. Newborns ≤ 35 weeks (gestational age)\n2. Newborns determined to not be clinically stable at delivery\n3. Newborns with Skin abnormalities",true,"ALL","35 Weeks","42 Weeks",{"count":22,"type":23},600,"ESTIMATED","INTERVENTIONAL",[26],"NA","The goals of this observational study is to assess whether a new advanced wireless skin sensor vital sign monitoring system can effectively monitor the vital signs of healthy newborn infants (≥ 35 weeks gestational age). The main aims of this Study are to:\n\n1. Assess feasibility\n2. Evaluate safety\n3. Determine accuracy of the wireless monitoring system, compared to the standard of care wired vital sign monitoring system, immediately after delivery and for the first 2h of age in the obstetrical center under unsupervised parents' care. The newborn infants participating in the Study will have both vital sign monitoring systems placed on their chest and limb. Their vital signs will be monitored for 2h consecutively.",[29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45],"Sudden Unexplained Infant Death","Apnea of Newborn","Newborn Morbidity","Newborn Asphyxia","Birth Outcome, Adverse","Birth Asphyxia","Pregnancy Related","Newborn; Vitality","ECG Electrode Site Reaction","Infant ALL","Infant Death","Infant, Newborn, Diseases","Infant Apnea","Infant Conditions","Parents","Delivery Problem for Fetus","Delivery Complication",[47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72],"Delivery Room","Newborn","Neonatal Resuscitation","Wireless Technology","Vital Sign Monitoring","Sudden Unexplained Post-Natal Collapse","SUPC","Obstetrical Center","Obstetrics","Neonate","Birth","Birthing Center","C-Section","Vaginal Delivery","Sensors","Heart Rate (HR)","Respiratory Rate (RR)","Blood Oxygen Saturation (SpO2)","Skin Temperature (Tskin)","Pulse Rate (PR)","International","Low-Income","Middle-Income","High-Income","Golden Hour","Post-Birth","RECRUITING","2026-05-05",{"date":76,"type":77},"2026-05-08","ACTUAL",{"date":79,"type":77},"2025-04-08",{"date":81,"type":23},"2027-12-30",{"name":83,"class":84},"Guilherme Sant'Anna, MD","OTHER",5,{"id":87,"slug":88,"hasResults":11,"nctId":89,"briefTitle":90,"officialTitle":90,"acronym":91,"eligibilityCriteria":92,"healthyVolunteers":11,"sex":93,"minAge":94,"maxAge":4,"enrollmentInfo":95,"targetDuration":4,"studyType":24,"phases":97,"briefSummary":98,"conditions":99,"keywords":101,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":106,"lastUpdatePostDateStruct":107,"startDateStruct":109,"completionDateStruct":111,"leadSponsor":113,"locationsCount":116},"100547683","training-for-urinary-leakage-improvement-after-pregnancy-100547683","NCT06411158","Training for Urinary Leakage Improvement After Pregnancy","TULIP","Inclusion Criteria:\n\n1. ≥18yo primiparous patient s\u002Fp singleton vaginal delivery (\\>32 weeks), approximately 6wk postpartum\n2. At increased risk of sustained pelvic floor disorders, as defined by\n\n   1. neonate ≥3.5kg, and\u002For\n   2. operative delivery (i.e., forceps or vacuum-assisted vaginal delivery), and\u002For\n   3. ≥2nd-degree perineal laceration\n3. Symptomatic, bothersome UI as defined by a score of ≥6 on the ICIQ-SF.\n\nExclusion Criteria:\n\n1. Inability to complete study assessments or procedures, per clinician judgment, or not available for 6mo postpartum follow-up\n2. Stillbirth or significant maternal or neonatal illness\n3. Non-English or non-Spanish speaking\n4. Perineal wound breakdown or cloaca observed on exam\n5. Severe pain with assessments of PFM integrity and\u002For strength\u002Ffunction\n6. Already engaged (since delivery) in in-person physical therapy for strengthening of the pelvic floor\n7. Unwilling or unable to upload and use external smartphone app(s)","FEMALE","18 Years",{"count":96,"type":23},216,[26],"This is a multi-center, randomized single-blind nonsurgical trial conducted in approximately 216 primiparous postpartum women at high risk for prolonged\u002Fsustained pelvic floor disorders with symptomatic, bothersome urinary incontinence (UI) amenable to nonsurgical treatment.\n\nTULIP is a 3-Arm trial with two active interventions (Arms 1 and 2) and a Patient Education control arm (Arm 3). Arm 1 consists of pelvic floor muscle training (PFMT). Arm 2 uses a home biofeedback device (leva®).\n\nThe primary outcome will be assessed at 6 months postpartum by blinded outcomes assessors, and follow-up will continue until 12 months postpartum.",[100,45],"Urinary Incontinence",[100,102,103,104,105],"Pelvic Floor Disorders","Physical Therapy","Biofeedback","Anal Incontinence","2025-12-29",{"date":108,"type":77},"2025-12-31",{"date":110,"type":77},"2024-11-12",{"date":112,"type":23},"2027-11-12",{"name":114,"class":115},"NICHD Pelvic Floor Disorders Network","NETWORK",7,{"id":118,"slug":119,"hasResults":11,"nctId":120,"briefTitle":121,"officialTitle":122,"acronym":4,"eligibilityCriteria":123,"healthyVolunteers":11,"sex":93,"minAge":4,"maxAge":4,"enrollmentInfo":124,"targetDuration":4,"studyType":126,"phases":4,"briefSummary":127,"conditions":128,"keywords":132,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":137,"lastUpdatePostDateStruct":138,"startDateStruct":140,"completionDateStruct":142,"leadSponsor":144,"locationsCount":146},"100614318","trends-in-the-administration-of-tranexamic-acid-for-postpartum-hemorrhage-100614318","NCT07278037","Trends in the Administration of Tranexamic Acid for Postpartum Hemorrhage","A Retrospective Analysis of the Longitudinal Pattern of Tranexamic Acid Administration in Parturients Undergoing Cesarean Delivery Complicated by Postpartum Hemorrhage","Inclusion Criteria:\n\n* 1\\. Patients underwent cesarean delivery with primary postpartum hemorrhage\n\nExclusion Criteria:\n\n1. Gestational age at less than 24 weeks\n2. Absence of the anesthetic record\n3. Received tranexamic acid in the antepartum period\n4. Blood loss less than 1,000 ml",{"count":125,"type":23},648,"OBSERVATIONAL","Postpartum hemorrhage (PPH) is the global leading cause of maternal death, with 20-30% of maternal deaths in Thailand linked to hemorrhage. The WOMAN Trial (2017) provided strong evidence that administering tranexamic acid (TXA)within three hours of bleeding onset lowered PPH-related mortality by 31%. Consequently, the World Health Organization (WHO) updated its guidelines, recommending TXA as part of the standard treatment package for all PPH cases. Following this, the use of TXA has been widely adopted globally and increased in Thailand. A recent study at a major Thai university hospital observed a significant increase in TXA administration after 2017. The current study aims to further analyze the recent growth rate of TXA use and its impact on obstetric and perinatal outcomes during cesarean deliveries with PPH.",[129,45,130,131],"Postpartum Hemorrhage","Cesarean Section Complications","Perinatal Problems",[133,134,135,136],"cesarean delivery","complications","postpartum hemorrhage","tranexamic acid","2025-12-16",{"date":139,"type":77},"2025-12-22",{"date":141,"type":77},"2025-12-01",{"date":143,"type":23},"2026-09-30",{"name":145,"class":84},"Mahidol University",1,{"id":148,"slug":149,"hasResults":11,"nctId":150,"briefTitle":151,"officialTitle":151,"acronym":152,"eligibilityCriteria":153,"healthyVolunteers":11,"sex":93,"minAge":94,"maxAge":154,"enrollmentInfo":155,"targetDuration":4,"studyType":24,"phases":156,"briefSummary":157,"conditions":158,"keywords":160,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":165,"lastUpdatePostDateStruct":166,"startDateStruct":168,"completionDateStruct":170,"leadSponsor":172,"locationsCount":146},"100445428","effect-of-oral-carbohydrate-intake--44kcal-per-hour-during-labour-on-the-rate-of-instrumental-vaginal-delivery-100445428","NCT05080309","Effect of Oral Carbohydrate Intake > 44kCal Per Hour During Labour on the Rate of Instrumental Vaginal Delivery","soliso-2","Inclusion Criteria:\n\n* nulliparous women\n* singleton pregnancy\n* social insurance\n* uncomplicated pregnancy\n* no contraindication to vaginal delivery\n\nExclusion Criteria:\n\n* scheduled caesarean section\n* labor \\\u003C 37 weeks of gestational age\n* cervical dilation \\> 8cm at inclusion\n* scheduled induced delivery\n* contraindication to pushing effort during labor and delivery\n* BMI \\> 40 kg\u002Fm2\n* medical history of diabetes mellitus, hypertension, heart disease","60 Years",{"count":22,"type":23},[26],"Carbohydrate intake during physical exercise improves muscle performance and decreases fatigue. We hypothesized that carbohydrate intake during labor which is a period of significant physical activity can decrease the instrumental vaginal delivery rate.\n\nIn a previous study we reported a trend toward a decrease in instrumental vaginal delivery and the mount of carbohydrate intake during labour. However due to some limitations no clear conclusion could be drawn.\n\nThe present study is designed to examine the relationship between a high calory oral intake (\\>44 kCal\u002Fhour during labour) and the rate of instrumental delivery.",[45,159,35],"Labor Long",[161,162,163,164],"labor","instrumental vaginal delivery","oral intake","nulliparous","2025-07-22",{"date":167,"type":77},"2025-07-25",{"date":169,"type":77},"2022-02-11",{"date":171,"type":23},"2028-09-03",{"name":173,"class":84},"University Hospital, Caen",{"id":175,"slug":176,"hasResults":11,"nctId":177,"briefTitle":178,"officialTitle":179,"acronym":180,"eligibilityCriteria":181,"healthyVolunteers":17,"sex":93,"minAge":182,"maxAge":183,"enrollmentInfo":184,"targetDuration":186,"studyType":126,"phases":4,"briefSummary":187,"conditions":188,"keywords":193,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":201,"lastUpdatePostDateStruct":202,"startDateStruct":204,"completionDateStruct":206,"leadSponsor":208,"locationsCount":210},"100567125","delivery-outcomes-by-aida-artificial-intelligence-dystocia-algorithm-analysis-100567125","NCT06664112","Delivery Outcomes by AIDA (Artificial Intelligence Dystocia Algorithm) Analysis","Study of Delivery Outcomes After AIDA (Artificial Intelligence Dystocia Algorithm) Analysis","AIDA","Inclusion Criteria:\n\nAll patients in pregnancy, nulliparae, candidates for spontaneous or induced labor, monitored by intrapartum ultrasound, collecting the ultrasound parameters of the labor progress.\n\n1. pregnants in labor, at first pregnancy\n2. gestational age ≥37 weeks of gestation\n\nExclusion Criteria:\n\nMultiparas who are candidates for cesarean section, premature labor and patients who do not agree to participate in the study (missing data relevant for the study). Exclusion criteria encompassed: breech, transverse, or oblique presentations; twin pregnancies; abnormal placental implantation; HELLP syndrome; coagulation disorders; uterine hyperstimulation (often referred to as \"terrified uterus\"); non-reassuring fetal heart rate; thick meconium; and cephalopelvic disproportion.\n\n1. Patients who are candidates for cesarean section.\n2. Patients in premature labor.\n3. Patients who do not agree to participate in the study.\n4. Exclusion criteria encompassed: breech, transverse, or oblique presentations; twin pregnancies; abnormal placental implantation; HELLP syndrome; coagulation disorders; uterine hyperstimulation (often referred to as \"terrified uterus\"); non-reassuring fetal heart rate; thick meconium; and cephalopelvic disproportion\n5. Missing data relevant for the study.","20 Years","45 Years",{"count":185,"type":23},1000,"12 Months","Aims:\n\nPrimary aim is to investigate outcomes of eutocic labor, evaluating intrapartum ultrasound parameters by AIDA method: Angle of progression (AoP), Asynclitism degree (AD), fetal head-symphysis distance (HSD), and midline angle (MLA).\n\nSecondary aim is to investigate outcomes of dystocic labor, evaluating intrapartum ultrasound parameters by AIDA method: Angle of progression (AoP), Asynclitism degree (AD), fetal head-symphysis distance (HSD), and midline angle (MLA).\n\nTertiary aim is to investigate of neonatal outcomes of eutocic labor: Apgar scores at 1 min, Apgar scores at 5 min.\n\nQuaternary aim is to investigate of neonatal outcomes of dystocic labor: Apgar scores at 1 min, Apgar scores at 5 min.",[45,189,190,191,192,44],"Delivery Problem","Delivery; Injury","Delivery; Injury, Maternal","Delivery;Breech;Stillbirth",[194,195,196,197,198,199,200],"Dystocia","Dystocic labor","Asynclitism","Intrapartum ultrasound","Labor outcomes","Delivery outcomes","Operative delivery complications","2024-11-28",{"date":203,"type":77},"2024-12-03",{"date":205,"type":77},"2024-09-30",{"date":207,"type":23},"2026-06-30",{"name":209,"class":115},"Centro di Ricerca Clinica Salentino",2,{"id":212,"slug":213,"hasResults":11,"nctId":214,"briefTitle":215,"officialTitle":216,"acronym":4,"eligibilityCriteria":217,"healthyVolunteers":17,"sex":93,"minAge":94,"maxAge":4,"enrollmentInfo":218,"targetDuration":4,"studyType":24,"phases":220,"briefSummary":221,"conditions":222,"keywords":4,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":224,"lastUpdatePostDateStruct":225,"startDateStruct":227,"completionDateStruct":229,"leadSponsor":231,"locationsCount":146},"100530024","time-of-oxytocin-initiation-at-2nd-stage-of-labor-and-adverse-outcomes-100530024","NCT06181396","Time of Oxytocin Initiation at 2nd Stage of Labor and Adverse Outcomes","Association Between Time of Oxytocin Initiation at 2nd Stage of Labor and Adverse Outcomes","Inclusion Criteria:\n\n1. Singleton pregnancy\n2. Maternal age ≥ 18 years' old\n3. Oxytocin administration initiated or renewed during second stage of labor\n\nExclusion Criteria:\n\n1. Maternal age \\\u003C 18 years' old\n2. Multiple gestation pregnancy\n3. Known fetal malformations\n4. Uterine scar",{"count":219,"type":23},120,[26],"Early oxytocin administration at the 2nd stage of labor is associated with a higher rate of vaginal delivery, shorter second stage duration, and fewer adverse maternal and neonatal outcomes.",[45,223],"Cesarean Delivery Affecting Fetus","2023-12-22",{"date":226,"type":77},"2023-12-26",{"date":228,"type":77},"2023-10-01",{"date":230,"type":23},"2026-10",{"name":232,"class":84},"Rambam Health Care Campus"]